Latest Transformation News

GoldArc Resources Ltd has completed a strategic rebrand and capital consolidation, raising A$3.2 million to accelerate exploration at its Leonora Gold Projects, where recent drilling confirmed significant high-grade gold mineralisation and identified new priority targets.

Macarthur Minerals bolstered its financial position through a nearly A$2 million entitlement offer and strengthened governance with a key board appointment, setting the stage for advancing its Lake Giles Iron Ore Project.

Merino & Co. initiates a new chapter with leadership changes and a strategic partnership to enter China’s premium apparel market, while investing heavily in growth during Q1 FY26.

RooLife Group (ASX, RLG) reported a strategic pivot in Q1 FY2026, landing major supply contracts worth $174 million and raising $2 million to fuel its own-brand product expansion.

Ballymore Resources has reported strong high-grade gold assay results from its Dittmer Project in Queensland, alongside key regulatory progress and a successful $4.5 million capital raise to fund ongoing exploration.

SQX Resources advances exploration in Queensland and secures 80% stake in two promising US gold projects, backed by a $2 million placement to accelerate development.

InteliCare successfully completed its largest aged care pilot at mecwacare’s Trescowthick Centre and secured $2 million in funding, while navigating a key leadership transition.

Locality Planning Energy Holdings Ltd (LPE) reports positive operating cashflow and significant debt reduction in Q3 2025, while preparing to launch its new broadband service by year-end.

Aguia Resources advances its phosphate operations in Brazil with new funding and plant upgrades, while a management overhaul in Colombia reveals a significant gold discovery at Santa Barbara.

Askari Metals has secured a major foothold in Ethiopia’s Arabian-Nubian Shield through the acquisition of the Nejo Gold and Copper Project, setting the stage for a high-impact exploration campaign supported by a new capital raise.

Cleo Diagnostics has secured positive FDA feedback and nearly 1,600 biobank samples, accelerating its ovarian cancer blood test development ahead of a planned 2026 U.S. market entry.

HeraMED has bolstered its cash position with a $1.98 million capital raise and is on the cusp of finalizing two pivotal U.S. commercial agreements, signaling a major step forward for its digital maternity care platform.